Clinical application of EGFR inhibitors in head and neck squamous cell cancer.

Cancer treatment and research

Volumn 139, Issue , 2008, Pages 135-152

  Astsaturov, Igor ^a   Cohen, Roger B ^a   Harari, Paul M ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; HEAD AND NECK TUMOR; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; REVIEW; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DRUG DELIVERY SYSTEMS; HEAD AND NECK NEOPLASMS; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

MLCS; MLOWN;

EID: 40049099008     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-0-387-36744-6_7     Document Type: Review

References (93)